Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery

Annals of Thoracic Surgery

Volumn 90, Issue 3, 2010, Pages 1040-1051

  Mahla, Elisabeth ^a   Metzler, Helfried ^a   Tantry, Udaya S ^b   Gurbel, Paul A ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CANGRELOR; CLOPIDOGREL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; ENDOPEROXIDE; PADGEM PROTEIN; PRASUGREL; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2; PROSTAGLANDIN G2; PROSTAGLANDIN H2; PROTON PUMP INHIBITOR; PRT 060128; PURINERGIC P2Y12 RECEPTOR; STATIN; THIENOPYRIDINE DERIVATIVE; THROMBOXANE A2; TICAGRELOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; THIOPHENE DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD TRANSFUSION; BODY WEIGHT; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INTESTINE ABSORPTION; INTESTINE INFARCTION; ISCHEMIA; KIDNEY FAILURE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAPHENOUS VEIN GRAFT; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; ANALOGS AND DERIVATIVES; CLINICAL TRIAL (TOPIC); ORAL DRUG ADMINISTRATION; THROMBOSIS;

ADMINISTRATION, ORAL; ASPIRIN; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY BYPASS; HUMANS; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PYRIDINES; THIOPHENES; THROMBOSIS; TICLOPIDINE;

EID: 77956152164     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.04.041     Document Type: Review

References (81)

1. Z.M. Ruggeri Platelets in atherothrombosis Nat Med 8 2002 1227 1234
2. P.A. Gurbel, K.P. Bliden, K.M. Hayes, and U. Tantry Platelet activation in myocardial ischemic syndromes Expert Rev Cardiovasc Ther 2 2004 535 545
3. C. Patrono, C. Baigent, J. Hirsh, and G. Roth Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 133 Suppl 2008 199S 233S (Pubitemid 351894914)
4. P.A. Gurbel, K.P. Bliden, and J. DiChiara Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study Circulation 115 2007 3156 3164
5. A. Undas, K. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Blood coagulation at the site of microvascular injury: effects of low-dose aspirin Blood 98 2001 2423 2431
6. B. Aktas, M. Pozgajova, and W. Bergmeier Aspirin induces platelet receptor shedding via ADAM17 (TACE) J Biol Chem 280 2005 39716 39722
7. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86 [Erratum in BMJ 2002;324:141.]
8. C. Baigent, L. Blackwell, and R. Collins Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
9. J.W. Eikelboom, G.J. Hankey, and J. Thom Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk Circulation 118 2008 1705 1712
10. J.D. Snoep, M.M.C. Hovens, J.C.J. Eikenboom, J.G. van der Bom, and M.V. Huisman Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis Arch Intern Med 167 2007 1593 1599
11. F. Santilli, B. Rocca, and R. De Cristofaro Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance." Am J Coll Cardiol 53 2009 667 677
12. M.M.C. Hovens, J.D. Snoep, J.C.J. Eikenboom, J.G. van der Bom, B.J.A. Mertens, and M.V. Huisman Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review Am Heart J 153 2007 175 181
13. N. Zimmermann, A. Wenk, and U. Kim Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 108 2003 542 547
14. P. Patrignani Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease Thromb Res 110 2003 281 286
15. F. Catella-Lawson, M.P. Reilly, and S.C. Kapoor Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 345 2001 1809 1817
16. L.J. Dacey, J.J. Munoz, and E.R. Johnson Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients Ann Thorac Surg 70 2000 1986 1990
17. K.A. Bybee, B.D. Powell, and U. Valeti Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting Circulation 112 2005 I286 I292
18. J.C. Sun, R. Whitlock, and J. Cheng The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies Eur Heart J 29 2008 1057 1071
19. D.T. Mangano Aspirin and mortality from coronary bypass surgery N Engl J Med 347 2002 1309 1317
20. V.A. Ferraris, S.P. Ferraris, and S.P. Saha Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann Thorac Surg 83 Suppl 2007 S27 S86
21. J. Dunning, M. Versteegh, and A. Fabbri Guideline on antiplatelet and anticoagulation management in cardiac surgery Eur J Cardiothorac Surg 34 2008 73 92
22. P.A. Gurbel, and U.S. Tantry Drug insight: clopidogrel nonresponsiveness Nat Clin Pract Cardiovasc Med 3 2006 387 395
23. Z. Xiao, and P. Throux Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome Am J Coll Cardiol 43 2004 1982 1988
24. P.A. Gurbel, K.P. Bliden, K. Guyer, N. Aggarwal, and U.S. Tantry Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting Thromb Res 119 2007 563 570
25. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913
26. T. Jernberg, C.D. Payne, and K.J. Winters Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease Eur Heart J 27 2006 1166 1173
27. P.A. Gurbel, K.P. Bliden, and K. Guyer Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study J Am Coll Cardiol 46 2005 1820 1826
28. D. Sibbing, S. Braun, and T. Morath Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
29. M.J. Price, S. Endemann, and R.R. Gollapudi Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000
30. M.J. Price, J.L. Coleman, S.R. Steinhubl, G.B. Wong, C.P. Cannon, and P.S. Teirstein Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers Am J Cardiol 98 2006 681 684
31. A.R. Shuldiner, J.R. O'Connell, and K.P. Bliden Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
32. W.C. Lau, L.A. Waskell, and P.B. Watkins Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction Circulation 107 2003 32 37
33. J.M. Siller-Matula, I. Lang, G. Christ, and B. Jilma Calcium-channel blockers reduce the antiplatelet effect of clopidogrel J Am Coll Cardiol 52 2008 1557 1563
34. M. Gilard, B. Arnaud, and J.-C. Cornily Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 2008 256 260
35. P.M. Ho, T.M. Maddox, and L. Wang Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 2009 937 944
36. J. Saw, D.M. Brennan, and S.R. Steinhubl Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial J Am Coll Cardiol 50 2007 291 295
37. P.A. Gurbel, R.C. Becker, K.G. Mann, S.R. Steinhubl, and A.D. Michelson Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 50 2007 1822 1834
38. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
39. A.D. Bowry, M.A. Brookhart, and N.K. Choudhry Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events Am J Cardiol 101 2008 960 966
40. S.R. Steinhubl, P.B. Berger, and J.T. Mann Iii Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
41. M.S. Sabatine, C.P. Cannon, and C.M. Gibson Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
42. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 [Erratum in N Engl J Med 2001;345:1506; N Engl J Med 2001;345:1716.]
43. T.J. Helton, A.A. Bavry, D.J. Kumbhani, S. Duggal, H. Roukoz, and D.L. Bhatt Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials Am J Cardiovasc Drugs 7 2007 289 297
44. D.L. Bhatt, K.A. Fox, and W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
45. S.B. King 3rd, S.C. Smith Jr, and J.W. Hirshfeld Jr 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 172 209
46. R.F. Storey, S. Husted, and R.A. Harrington Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes J Am Coll Cardiol 50 2007 1852 1856
47. A.B. Greenbaum, C.L. Grines, and J.A. Bittl Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial Am Heart J 151 2006 689 e1- e10
48. P.A. Gurbel, K.P. Bliden, and M.J. Antonino The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19 (*)2 genotype: first experience in patients J Thromb Haemost 8 2010 43 53
49. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
50. P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
51. K.A. Fox, S.R. Mehta, and R. Peters Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
52. R. Ebrahimi, C. Dyke, and R. Mehran Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 53 2009 1965 1972
53. R.H. Mehta, M.T. Roe, and J. Mulgund Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery J Am Coll Cardiol 48 2006 281 286
54. S. Yende, and R.G. Wunderink Effect of clopidogrel on bleeding after coronary artery bypass surgery Crit Care Med 29 2001 2271 2275
55. R.H. Hongo, J. Ley, S.E. Dick, and R.R. Yee The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting J Am Coll Cardiol 40 2002 231 237
56. J.G. Ray, S. Deniz, and A. Olivieri Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel BMC Cardiovasc Disord 3 2003 3
57. H. Karabulut, F. Toraman, S. Evrenkaya, O. Goksel, S. Tarcan, and C. Alhan Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery Eur J Cardiothorac Surg 25 2004 419 423
58. L. Chen, A.W. Bracey, and R. Radovancevic Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting J Thorac Cardiovasc Surg 128 2004 425 431
59. E.I. Kapetanakis, D.A. Medlam, and S.W. Boyce Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 26 2005 576 583
60. R. Ascione, A. Ghosh, C.A. Rogers, A. Cohen, C. Monk, and G.D. Angelini In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution Ann Thorac Surg 79 2005 1210 1216
61. F. Nurozler, T. Kutlu, G. Kucuk, and C. Okten Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery Interact Cardiovasc Thorac Surg 4 2005 546 549
62. C. von Heymann, U. Redlich, and M. Moritz Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss Thorac Cardiovasc Surg 53 2005 341 345
63. D.S. McLean, M.S. Sabatine, W. Guo, C.H. McCabe, and C.P. Cannon Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28 J Thromb Thrombolysis 24 2007 85 91
64. W. Kang, T.E. Theman, J.F. Reed 3rd, J. Stoltzfus, and N. Weger The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery J Surg Educ 64 2007 88 92
65. J.K. Shim, Y.S. Choi, Y.J. Oh, S.O. Bang, K.J. Yoo, and Y.L. Kwak Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery J Thorac Cardiovasc Surg 134 2007 59 64
66. S.M. Picker, T. Kaleta, K. Hekmat, S. Kampe, and B.S. Gathof Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome Eur J Anaesthesiol 24 2007 332 339
67. M.G. Reichert, A.H. Robinson, J.A. Travis, J.W. Hammon, N.D. Kon, and E.H. Kincaid Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting Pharmacotherapy 28 2008 151 155
68. J.H.-J. Kim, L.K. Newby, and R.M. Clare Clopidogrel use and bleeding after coronary artery bypass graft surgery Am Heart J 156 2008 886 892
69. J.S. Berger, C.B. Frye, Q. Harshaw, F.H. Edwards, S.R. Steinhubl, and R.C. Becker Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol 52 2008 1693 1701
70. S.W. Song, Y.N. Youn, G. Yi, S. Lee, and K.J. Yoo Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome Circ J 72 2008 626 632
71. G.N. Vaccarino, J. Thierer, and M. Albertal Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis J Thorac Cardiovasc Surg 137 2009 309 313
72. G.G. Biondi-Zoccai, M. Lotrionte, and P. Agostoni A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease Eur Heart J 27 2006 2667 2674
73. P.M. Ho, E.D. Peterson, and L. Wang Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome JAMA 299 2008 532 539
74. M. Thielmann, P. Massoudy, and M. Neuhauser Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes Circulation 114 2006 I448 I453
75. D.H. Kim, C. Daskalakis, and S.C. Silvestry Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting J Thorac Cardiovasc Surg 138 2009 1377 1384
76. R. Lorusso, G. De Cicco, and C. Beghi Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG Int J Cardiol 118 2007 164 169
77. D.M. Monroe, and M. Hoffman What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26 2006 41 48
78. R. Altman, A. Scazziota, M. de Lourdes Herrera, and C. Gonzalez Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation J Thromb Haemost 4 2006 2022 2027
79. B. Lauritzen, M. Tranholm, and M. Ezban rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats J Thromb Haemost 7 2009 651 657
80. A. Ouattara, H. Bouzguenda, and Y. Le Manach Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin Eur Heart J 28 2007 1025 1032
81. D.A. Fergusson, P.C. Hebert, and C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331